Search research articles
Contact Us
Filters
Showing results (311-320 of 337) with videos related to
Page
of 34
Sort By:
Agents and Actions
|
December 1, 1986
Autoimmune disorders--analysis by study of T cells, implications and speculations
M Feldmann, M Londei, P de Berardinis, et al.
British Journal of Rheumatology
|
November 1, 1992
The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease
S M Brookes, Y A Pandolfino, T J Mitchell, et al.
Developments in Biologicals
|
May 24, 2003
Consequences of immunogenicity to the therapeutic monoclonal antibodies ReoPro and Remicade
C L Wagner, A Schantz, E Barnathan, et al.
Arthritis and Rheumatism
|
December 1, 1993
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha
M J Elliott, R N Maini, M Feldmann, et al.
Arthritis and Rheumatism
|
October 1, 1992
Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases
A P Cope, D Aderka, M Doherty, et al.
Arthritis and Rheumatism
|
July 1, 1996
Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis
P P Tak, P C Taylor, F C Breedveld, et al.
Immunological Reviews
|
April 1, 1995
Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease
R N Maini, M J Elliott, F M Brennan, et al.
Journal of Molecular Biology
|
October 7, 1994
Crystallization and preliminary X-ray analysis of the Fab fragment of a human monoclonal IgM rheumatoid factor (2A2)
M K Sohi, B J Sutton, A L Corper, et al.
Arthritis and Rheumatism
|
April 13, 2004
Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis
P C Taylor, A Steuer, J Gruber, et al.
Arthritis and Rheumatism
|
December 31, 2005
Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis
P C Taylor, A Steuer, J Gruber, et al.
Page
of 34
Search research articles
Search
Showing results (311-320 of 337) with videos related to
Sort By:
Page
of 34
Agents and Actions
|
December 1, 1986
Autoimmune disorders--analysis by study of T cells, implications and speculations
M Feldmann, M Londei, P de Berardinis, et al.
British Journal of Rheumatology
|
November 1, 1992
The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease
S M Brookes, Y A Pandolfino, T J Mitchell, et al.
Developments in Biologicals
|
May 24, 2003
Consequences of immunogenicity to the therapeutic monoclonal antibodies ReoPro and Remicade
C L Wagner, A Schantz, E Barnathan, et al.
Arthritis and Rheumatism
|
December 1, 1993
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha
M J Elliott, R N Maini, M Feldmann, et al.
Arthritis and Rheumatism
|
October 1, 1992
Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases
A P Cope, D Aderka, M Doherty, et al.
Arthritis and Rheumatism
|
July 1, 1996
Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis
P P Tak, P C Taylor, F C Breedveld, et al.
Immunological Reviews
|
April 1, 1995
Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease
R N Maini, M J Elliott, F M Brennan, et al.
Journal of Molecular Biology
|
October 7, 1994
Crystallization and preliminary X-ray analysis of the Fab fragment of a human monoclonal IgM rheumatoid factor (2A2)
M K Sohi, B J Sutton, A L Corper, et al.
Arthritis and Rheumatism
|
April 13, 2004
Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis
P C Taylor, A Steuer, J Gruber, et al.
Arthritis and Rheumatism
|
December 31, 2005
Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis
P C Taylor, A Steuer, J Gruber, et al.
Page
of 34